NASDAQIndustrialsConglomeratesSnapshot 2026-11-04
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.
Next-FY EPS estimate change · 30 days
Matching fiscal periods, usable estimates and at least one analyst are required.
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
The calculation requires same-period, same-provider snapshots, positive EPS, at least one analyst and a baseline within three days of the requested lookback.
The EPS and P/E reference is not available for FBYD yet.
| Measure / period | Management expectations | Analyst expectations |
|---|
Management figures unavailable.
Current consensus figures unavailable.
Three published thesis conditions, with dated milestones shown separately.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
Negative cash flow from operations improves toward break-even | Cash flow from operations improved but remains negative at -$2.75M. | Intact | cash flow from operations worsens beyond -$2.75M next quarter | Cash from operations: $2.405M FY2026-Q2; GAAP. Published target: negative cash flow from operations > -$2.75M next quarter. The target does not explicitly identify fiscal versus calendar quarters. Aug 13, 20262,405,000 USD · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Compare these dated observations with the operating requirements above
Comparable estimate history is unavailable.
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Compare required revenue and earningsMonthly analyst history is unavailable.
Recent actions · Oct 6–Nov 4 · 0 recorded
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Nov 13, 2026
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
Observed price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
This is a high-risk growth and execution story, not yet a proven durable compounder. The thesis is in a watch state, and its signal has shifted from mildly favorable to mixed.
The valuation is expensive versus peers, with a roughly 9.8% premium in the evidence snapshot, though confidence in that estimate is low. The market appears to give weight to future growth potential, while weak execution quality makes that premium more fragile.
Near term, profitability and cash flow may remain uneven: FBYD moved from positive operating income in Q1 to a net loss and an Adjusted EBITDA loss in Q2, while operating cash flow remained negative. Management continues to prioritize doubling FCG revenue, improving profitability, and managing cash use, but FCG revenue has shown only modest growth so far.
The multi-year thesis depends on management turning its stated priorities into sustained revenue growth, stronger profitability, and improved cash generation. Near term, a guidance cut would add pressure, while results and guidance from industrial bellwethers could either support or weaken the sector backdrop.
Over the next 1 to 3 years, FBYD’s thesis rests on execution catching up with its growth ambitions; current evidence shows mixed progress and high risk. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Stated in 2 of 2 supplied quarters. Management reported: “Magpuri, (20) the outcome of pending, threatened and future legal proceedings, (21) our continued compliance with Nasdaq continued listing standards, (22) risks related to our Up-C entity structure and the fact that we may be required to make substantial payments to certain unitholders under our Tax Receivable Agreement, and (23) the risks disclosed under the caption “Risk Factors” in the Company’s most recent Annual Report on Form 10-K, and the Company’s other filings with the Securities and Exchange Commission.”
Net income turns positive and sustains | Net income rose from -$0.296M to $3.07M, showing progress toward profitability. | Intact | net income falls below $0 in next quarter | Net income: $-160,000 FY2026-Q2; GAAP. Published target: >= $3.07M net income next quarter. The target does not explicitly identify fiscal versus calendar quarters. Aug 13, 2026-160,000 USD · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management contextStated in 2 of 2 supplied quarters. Management reported: “Adjusted EBITDA Falcon's Beyond generated Adjusted EBITDA (1) loss of $5.2 million in the three month period ended June 30, 2026.” “Adjusted EBITDA Falcon's Beyond generated Adjusted EBITDA (1) loss of $4.6 million compared to $8.1 million Adjusted EBITDA loss for the comparative period driven by the improvement in consolidated net income previously described.” Delivery assessment Nov 4, 2026 |
Operating income improves to positive territory | Falcon's Beyond Global improved operating income from -$2.04M to $6.49M in one quarter. | Intact | operating income falls below $0 in next quarter | Operating income: $-262,000 FY2026-Q2; GAAP. Published target: >= $6.49M operating income next quarter. The target does not explicitly identify fiscal versus calendar quarters. Aug 13, 2026-262,000 USD · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management contextStated in 2 of 2 supplied quarters. Management reported: “Adjusted EBITDA Falcon's Beyond generated Adjusted EBITDA (1) loss of $5.2 million in the three month period ended June 30, 2026.” “Adjusted EBITDA Falcon's Beyond generated Adjusted EBITDA (1) loss of $4.6 million compared to $8.1 million Adjusted EBITDA loss for the comparative period driven by the improvement in consolidated net income previously described.” Delivery assessment Nov 4, 2026 |
Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
Individual price-target observations are unavailable.
0 raises · 0 cuts · 0 unchanged · 0 without a comparable prior
Oct 6, 2026–Nov 4, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
3 of 3 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.